(KNSL) Kinsale Capital - Overview
Stock: Property, Casualty, Commercial, Personal, Insurance
| Risk 5d forecast | |
|---|---|
| Volatility | 40.4% |
| Relative Tail Risk | -17.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.36 |
| Alpha | -23.96 |
| Character TTM | |
|---|---|
| Beta | 0.500 |
| Beta Downside | 0.477 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.12% |
| CAGR/Max DD | 0.15 |
EPS (Earnings per Share)
Revenue
Description: KNSL Kinsale Capital January 03, 2026
Kinsale Capital Group (NYSE:KNSL) is a U.S.-based property and casualty insurer that underwrites a broad suite of commercial lines-including construction, energy, professional liability, and agribusiness-as well as high-value personal lines such as luxury homeowners. The firm distributes its products through an independent broker network across all 50 states, DC, Puerto Rico, and the U.S. Virgin Islands. Founded in 2009 and headquartered in Richmond, Virginia, Kinsale focuses on niche, higher-margin segments within the P&C market.
Recent performance metrics (FY 2023) show a combined ratio of roughly 85%, indicating underwriting profitability, and net written premiums of about $1.2 billion, up 7% year-over-year. The company generated a return on equity near 12% and posted earnings per share growth of 15% versus the prior year, reflecting both disciplined underwriting and a modest investment-income boost from a higher-interest-rate environment.
Key drivers for Kinsale’s outlook include: (1) the frequency and severity of natural catastrophes, which can compress loss ratios in its commercial property lines; (2) inflation in construction and labor costs, raising claim severities but also allowing for premium price-adjustments; and (3) the broader macro-trend of rising interest rates, which improves investment yields but may increase policyholder lapse rates in price-sensitive segments.
For a deeper, data-rich analysis of Kinsale’s valuation and risk profile, you may find the free research tools on ValueRay useful.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 503.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA -3.75 > 1.0 |
| NWC/Revenue: -185.3% < 20% (prev 232.5%; Δ -417.8% < -1%) |
| CFO/TA 0.17 > 3% & CFO 1.02b > Net Income 503.6m |
| Net Debt (61.0m) to EBITDA (644.9m): 0.09 < 3 |
| Current Ratio: 0.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (23.2m) vs 12m ago -0.72% < -2% |
| Gross Margin: 46.03% > 18% (prev 0.43%; Δ 4560 % > 0.5%) |
| Asset Turnover: 34.29% > 50% (prev 32.49%; Δ 1.80% > 0%) |
| Interest Coverage Ratio: 59.58 > 6 (EBITDA TTM 644.9m / Interest Expense TTM 10.6m) |
Altman Z'' -1.57
| A: -0.57 (Total Current Assets 288.0m - Total Current Liabilities 3.76b) / Total Assets 6.04b |
| B: 0.26 (Retained Earnings 1.58b / Total Assets 6.04b) |
| C: 0.12 (EBIT TTM 634.3m / Avg Total Assets 5.47b) |
| D: 0.54 (Book Value of Equity 1.96b / Total Liabilities 3.65b) |
| Altman-Z'' Score: -1.57 = D |
Beneish M
| DSRI: 0.22 (Receivables 124.6m/477.9m, Revenue 1.87b/1.59b) |
| GMI: 0.93 (GM 46.03% / 42.86%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.18 (Revenue 1.87b / 1.59b) |
| TATA: -0.08 (NI 503.6m - CFO 1.02b) / TA 6.04b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of KNSL shares?
Over the past week, the price has changed by -6.73%, over one month by -7.68%, over three months by -1.41% and over the past year by -14.93%.
Is KNSL a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the KNSL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 442.3 | 18.3% |
| Analysts Target Price | 442.3 | 18.3% |
KNSL Fundamental Data Overview February 17, 2026
P/E Forward = 17.8891
P/S = 4.6168
P/B = 4.4082
P/EG = 1.1927
Revenue TTM = 1.87b USD
EBIT TTM = 634.3m USD
EBITDA TTM = 644.9m USD
Long Term Debt = 199.3m USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 224.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 61.0m USD (from netDebt column, last quarter)
Enterprise Value = 8.71b USD (8.65b + Debt 224.4m - CCE 167.2m)
Interest Coverage Ratio = 59.58 (Ebit TTM 634.3m / Interest Expense TTM 10.6m)
EV/FCF = 9.06x (Enterprise Value 8.71b / FCF TTM 961.5m)
FCF Yield = 11.04% (FCF TTM 961.5m / Enterprise Value 8.71b)
FCF Margin = 51.31% (FCF TTM 961.5m / Revenue TTM 1.87b)
Net Margin = 26.87% (Net Income TTM 503.6m / Revenue TTM 1.87b)
Gross Margin = 46.03% ((Revenue TTM 1.87b - Cost of Revenue TTM 1.01b) / Revenue TTM)
Gross Margin QoQ = 55.88% (prev 45.24%)
Tobins Q-Ratio = 1.44 (Enterprise Value 8.71b / Total Assets 6.04b)
Interest Expense / Debt = 1.33% (Interest Expense 2.98m / Debt 224.4m)
Taxrate = 20.71% (36.2m / 174.8m)
NOPAT = 502.9m (EBIT 634.3m * (1 - 20.71%))
Current Ratio = 0.08 (Total Current Assets 288.0m / Total Current Liabilities 3.76b)
Debt / Equity = 0.11 (Debt 224.4m / totalStockholderEquity, last quarter 1.96b)
Debt / EBITDA = 0.09 (Net Debt 61.0m / EBITDA 644.9m)
Debt / FCF = 0.06 (Net Debt 61.0m / FCF TTM 961.5m)
Total Stockholder Equity = 1.78b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.22% (Net Income 503.6m / Total Assets 6.04b)
RoE = 28.25% (Net Income TTM 503.6m / Total Stockholder Equity 1.78b)
RoCE = 32.00% (EBIT 634.3m / Capital Employed (Equity 1.78b + L.T.Debt 199.3m))
RoIC = 26.29% (NOPAT 502.9m / Invested Capital 1.91b)
WACC = 7.59% (E(8.65b)/V(8.88b) * Re(7.76%) + D(224.4m)/V(8.88b) * Rd(1.33%) * (1-Tc(0.21)))
Discount Rate = 7.76% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.34%
[DCF Debug] Terminal Value 82.60% ; FCFF base≈961.1m ; Y1≈1.19b ; Y5≈2.02b
Fair Price DCF = 1596 (EV 37.20b - Net Debt 61.0m = Equity 37.14b / Shares 23.3m; r=7.59% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 90.54 | EPS CAGR: 40.34% | SUE: 4.0 | # QB: 15
Revenue Correlation: 97.05 | Revenue CAGR: 30.07% | SUE: 1.10 | # QB: 3
EPS next Quarter (2026-03-31): EPS=4.69 | Chg30d=-0.026 | Revisions Net=+2 | Analysts=9
EPS current Year (2026-12-31): EPS=20.25 | Chg30d=-0.271 | Revisions Net=-1 | Growth EPS=+3.8% | Growth Revenue=+3.8%
EPS next Year (2027-12-31): EPS=22.47 | Chg30d=-0.372 | Revisions Net=-2 | Growth EPS=+10.9% | Growth Revenue=+10.2%